Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ARID1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TRIB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FADS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL35A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
B4GALNT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DGKA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00968 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SIK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEMA4D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EGR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLSPN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRSF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIGL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC81 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ID3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AZIN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FPR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPPL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928371 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on